Pub. Date : 2022 Apr
PMID : 35170228
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Selumetinib is an oral, potent, and highly selective allosteric MEK1/2 inhibitor approved for the treatment of pediatric patients (aged <=2 years) with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas. | AZD 6244 | neurofibromin 1 | Homo sapiens |